VHB Lifesciences
VHB Life Sciences
VHB Life Sciences
VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences
VHB Lifesciences VHB Lifesciences VHB Lifesciences VHB Lifesciences

Our Products

VHB Lifesciences
api
VHB Lifesciences
VHB Lifesciences
Formulation
VHB Lifesciences
VHB Lifesciences
Field Force
VHB Lifesciences
VHB Lifesciences

Company Video

VHB Lifesciences
Home » Our Products » Therapeutic Segmentation » Oncology
 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9  Next »

Oncology

We supply variety of amphotericin-b injection, thioguanine tablets, antimetabolite tablets, lymphocytic leukemia medicine etc.

Carboteen 450mg/45ml

Carboteen 450mg 45ml Generic:
carboplatin

classification:
alkylating like agents, miscellaneous agent.

mechanism of action:
covalently binds to dna with preferential binding to the n-7 position of guanine and adenine. Reacts with two different sites on dna to produce cross-links, either intrastrand (<90%) or interstrand (<5%). Formation of dna adducts results in inhibition of dna synthesis and function as well as inhibition of transcription. Binding to nuclear and cytoplasmic proteins may result in cytotoxic effects. Cell cycle-nonspecific agent.

composition:
each ml contains:
carboplatin usp…. . 10mg

indications:
  • ovarian cancer.
  • germ cell tumors.
  • head and neck cancer.
  • small cell and non-small cell lung cancer.
  • bladder cancer.
  • relapsed and refractory acute leukemia.
  • endometrial cancer.


storage:
unopened vials of carboplatin aqueous solution injection are stable to the date indicated on the package when stored at 25° c excursions permitted from 15°-30° c (59°-86° f). Protect from light.

strengths:
450mg/45ml
» Yes! I am Interested

Detaxl 20mg/0.5ml

Moxifen

Moxifen Generic:
tamoxifen

classification:
anti hormone.

mechanism of action:
tamoxifen and several of its metabolites (particularly 4-hydroxytamoxifen) bind to nuclear oestrogen receptors in oestrogen-sensitive tissues, and also to a microsomal protein termed the 'anti-oestrogen binding site'.
tamoxifen interferes with the physiological sequence by which oestrogen binds to its receptor, is translocated in the nucleus and then activates messenger rna synthesis. Although the tamoxifen-receptor complex is transported in the nucleus in the same way as oestrogen-receptor complex, it fails to activate synthesis of mrna.

indications:
  • early breast cancer in women with estrogen receptor positive tumors.
  • women with hormone responsive locally advanced/ metastatic breast cancer.


storage:
  • stored at room temperature, protected from light.

Looking for Product Name ?